Mariacarmela Santarpia Selected Research

Mariacarmela Santarpia Research Topics

Disease

49	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 12/2005
41	Neoplasms (Cancer) 02/2024 - 12/2005
22	Lung Neoplasms (Lung Cancer) 05/2023 - 08/2006
8	Disease Progression 03/2024 - 09/2013
7	Neoplasm Metastasis (Metastasis) 11/2023 - 06/2015
6	Melanoma (Melanoma, Malignant) 02/2024 - 10/2015
5	Adenocarcinoma of Lung 09/2022 - 03/2006
4	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2008
3	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 01/2022
3	Drug-Related Side Effects and Adverse Reactions 03/2023 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2021
2	Cardiotoxicity 11/2022 - 01/2021
2	Adenocarcinoma 09/2022 - 09/2013
1	Thyroiditis 02/2024
1	Hypothyroidism 02/2024
1	Addison Disease (Addison's Disease) 02/2024
1	Thyrotoxicosis 02/2024
1	Cognitive Dysfunction 11/2023
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2023
1	Sarcoma (Soft Tissue Sarcoma) 02/2023
1	Brain Diseases (Brain Disorder) 05/2022
1	Retinoblastoma (Glioblastoma, Retinal) 02/2022
1	Thromboembolism 01/2022
1	Capillary Leak Syndrome 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2020
1	Squamous Cell Carcinoma of Head and Neck 11/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2018
1	Circulating Neoplastic Cells 04/2018
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2017

Drug/Important Bio-Agent (IBA)

17	ErbB Receptors (EGF Receptor)IBA 04/2024 - 03/2006
14	Tyrosine Kinase InhibitorsIBA 08/2023 - 02/2007
12	Immune Checkpoint InhibitorsIBA 02/2024 - 09/2015
8	osimertinibIBA 03/2024 - 01/2017
8	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2008
6	AntibodiesIBA 02/2023 - 01/2015
6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 12/2005
6	Messenger RNA (mRNA)IBA 01/2019 - 12/2005
5	PlatinumIBA 11/2023 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2016
5	Circulating Tumor DNAIBA 09/2022 - 01/2016
5	Anaplastic Lymphoma KinaseIBA 05/2022 - 06/2015
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2023 - 06/2011
3	pembrolizumabIBA 02/2024 - 01/2015
3	Gefitinib (Iressa)FDA Link 09/2022 - 06/2011
3	Gemcitabine FDA Link 01/2021 - 01/2017
3	CrizotinibIBA 06/2017 - 03/2014
3	Docetaxel (Taxotere)FDA Link 01/2017 - 12/2005
3	DNA (Deoxyribonucleic Acid)IBA 08/2016 - 12/2005
2	Programmed Cell Death 1 ReceptorIBA 02/2023 - 09/2015
2	alectinibIBA 05/2022 - 06/2015
2	MicroRNAs (MicroRNA)IBA 04/2022 - 03/2006
2	Phosphotransferases (Kinase)IBA 06/2020 - 10/2015
2	Temozolomide (Temodar)FDA LinkGeneric 12/2018 - 04/2008
2	Monoclonal AntibodiesIBA 01/2017 - 09/2015
2	VaccinesIBA 12/2016 - 01/2016
2	NivolumabIBA 09/2015 - 01/2015
1	regorafenibIBA 08/2023
1	encorafenibIBA 08/2023
1	atezolizumabIBA 01/2023
1	enfortumab vedotinIBA 01/2023
1	durvalumabIBA 01/2023
1	SteroidsIBA 11/2022
1	Melanocyte-Stimulating Hormones (MSH)IBA 02/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	eribulin FDA Link 01/2021
1	Hormones (Hormone)IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	cemiplimabIBA 11/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2020
1	Drug CombinationsIBA 11/2019
1	docosahexaenoylascorbic acid (DHA-As)IBA 11/2019
1	artenimol (dihydroartemisinin)IBA 11/2019
1	dacomitinibIBA 09/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	integrin-linked kinaseIBA 01/2019
1	veliparibIBA 12/2018
1	Epidermal Growth Factor (EGF)IBA 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	5'-Nucleotidase (5' Nucleotidase)IBA 03/2018
1	B7-H1 AntigenIBA 01/2018
1	ceritinibIBA 01/2017
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2017
1	AmphiregulinIBA 01/2017
1	Angiogenesis InhibitorsIBA 01/2017

Therapy/Procedure

28	Therapeutics 04/2024 - 02/2007
24	Drug Therapy (Chemotherapy) 02/2023 - 12/2005
20	Immunotherapy 11/2023 - 01/2015
4	Radiotherapy 11/2023 - 09/2013
2	Adjuvant Chemotherapy 11/2023 - 01/2011
1	Neoadjuvant Therapy 01/2021
1	Combination Drug Therapy (Combination Chemotherapy) 03/2018
1	Lasers (Laser) 03/2018
1	Precision Medicine 01/2017